Inspire Medical Systems Stock (NYSE:INSP)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$146.24

52W Range

$123.00 - $257.40

50D Avg

$169.01

200D Avg

$180.92

Market Cap

$4.37B

Avg Vol (3M)

$505.25K

Beta

1.39

Div Yield

-

INSP Company Profile


Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,246

IPO Date

May 03, 2018

Website

INSP Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Operating Segment$802.80M

Fiscal year ends in Dec 24 | Currency in USD

INSP Financial Summary


Dec 24Dec 23Dec 22
Revenue$802.80M$624.80M$407.86M
Operating Income$36.08M$-40.27M$-47.59M
Net Income$53.51M$-21.15M$-44.88M
EBITDA$36.08M$-17.06M$-39.69M
Basic EPS$1.80$-0.72$-1.60
Diluted EPS$1.75$-0.72$-1.60

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 10, 25 | 5:00 PM
Q3 24Nov 04, 24 | 5:00 PM
Q2 24Aug 06, 24 | 5:00 PM

Peer Comparison


TickerCompany
PENPenumbra, Inc.
TNDMTandem Diabetes Care, Inc.
CLPTClearPoint Neuro, Inc.
PODDInsulet Corporation
GMEDGlobus Medical, Inc.
GKOSGlaukos Corporation
TMDXTransMedics Group, Inc.
INMDInMode Ltd.
OMOutset Medical, Inc.
DXCMDexCom, Inc.
NVCRNovoCure Limited